Created On: 2020-07-15
Record Count: 4
- HIV / AIDs
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 245930
The Product means any product developed by or on behalf Licensee, the manufacture, use or sale of which is covered by a Valid Claim of the Patents in the country of manufacture, use or sale.
Service means any service provided by Licensee in connection with a Product in the Field.
IPSCIO Record ID: 275802
Xcellerateâ„¢ Technology means the Licensor Patents and Licensor Know-How.
Licensor Patents means, to the extent owned or Controlled by Licensor, or owned or Controlled jointly by Licensor and Licensee:
6,352,694 – Methods for inducing a population of T cells to proliferate using agents which recognize TCR/CD3 and ligands which stimulate an accessory molecule on the surface of the T cells
5,858,358 – Methods for selectively stimulating proliferation of T cells
5,883,223 – CD9 antigen peptides and antibodies thereto
Licensor Know-How means any and all technical information, processes, formulae, data, engineering, inventions, chemical compounds, know-how and trade secrets owned or Controlled by Licensor that relate to the Xcellerated T Cellsâ„¢, Xcellerateâ„¢ II Process and the Xcellerateâ„¢ III Process and any other proprietary information.
Xcellerated T Cellsâ„¢â€ means the T cells that are produced by the use of the Xcellerateâ„¢ Technology, including but not limited to the use of the Licensor DynabeadsÂ®, Xcellerateâ„¢ II Process or Xcellerateâ„¢ III Process or derivatives thereof.
Xcellerateâ„¢ II Processâ€ means a static process configuration as it exists as of the Effective Date and is defined in Xcyte Therapies Master Production Records MPR 11-0002 & 11-0005 submitted to FDA on September 19, 2001.
Xcellerateâ„¢ III Process means the process configuration based on the WaveBioreactor as it exists as of the Effective Date and is defined in Licensor Therapies Master Production Records MPR 11-0006 & 11-0007 submitted to the FDA on May 15, 2003.
Licensor DynabeadsÂ®â€ means XR-CD3 and XR-CD28 antibodies produced at Lonza Biologics that are conjugated to super-paramagnetic Dynaspheres MS-4.5-REK particles at Dynal Biotech A.S.A.
IPSCIO Record ID: 246212
Property No. 62/219,652 IN VIVO ACTIVATION OF NATURAL KILLER CELLS
Licensee, a cancer immunotherapy company focused on developing therapies that harness the patient's innate immune system to attack their cancer.
IPSCIO Record ID: 243435